Purchase Order HT001426PE037
- Not listed
- This is a $70,741.88 firm fixed-price purchase order awarded to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices, for the maintenance of Spectra Optia apheresis systems used in the stem cell transplant program of the Defense Health Agency (DHA). The purchase order has an ultimate completion date of November 29, 2027. Terumo BCT Inc. provides a wide range of products and services to federal agencies, including blood bag systems, tubing sets, cell washing equipment, and...
- The Defense Health Agency awarded a $203,822.11 firm fixed-price purchase order to Terumo BCT Inc. (doing business as Caridianbct Inc.) on January 24, 2024, for annual maintenance and repair services of medical equipment. The contract extends through January 21, 2028, and will be performed at the agency's Bethesda, Maryland facility. No small business set-aside was used for this procurement, reflecting the specialized technical expertise required for maintaining advanced medical equipment in a...
- The Defense Health Agency awarded a $207.3K firm fixed-price purchase order to Terumo BCT Inc. on September 30, 2020, for the supply and drop shipment of 180 Teruflex blood bag systems. The contract was awarded without a small business set-aside and carries an ultimate completion date of August 15, 2025. Performance will take place in Denver, Colorado, where Terumo BCT Inc. maintains its headquarters. The solicitation was posted on September 15, 2020, with a due date of September 29, 2020,...
- This federal contract was awarded by the Defense Health Agency to Terumo BCT Inc., a manufacturer of medical devices and provider of services related to blood and cell technologies. The $130,000.00 contract is for the provision of a Spectra Optia apheresis system, a device used for blood collection and processing. The contract has a firm fixed price pricing type and a completion date of June 9, 2017. Though the award was not set aside for a specific business type, Terumo BCT has previously...
- This federal contract award was made by the Defense Health Agency to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and provider of blood and cell technology services. The award, valued at $14,450.00, is for the supply of a Spectra Optia Exchange Kit #10220. The contract is a firm-fixed-price purchase order with an ultimate completion date of August 31, 2015. The award is not associated with a set-aside program. Terumo BCT Inc. operates as Terumo Bct, Inc....
- The Defense Health Agency awarded a $275,550.25 firm fixed-price purchase order to Terumo BCT Inc. (doing business as Caridianbct Inc.) for blood sampling services, with performance to be completed by September 23, 2026. The contract was awarded on September 24, 2025, with work to be performed in Bethesda, Maryland. This procurement represents part of the Defense Health Agency's medical support operations and reflects the agency's ongoing requirement for specialized blood collection and sampling...
- This federal contract award to Terumo BCT, Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services, is for the procurement of 2 Spectra Optia Apheresis Systems, catalog number 61000. The contract, valued at $183,580.50, is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract has an ultimate completion date of June 30, 2025 and was awarded on May 29, 2025....
- The Defense Health Agency awarded a $112,290.35 firm fixed-price purchase order to Terumo BCT Inc. (doing business as Caridianbct Inc.) on November 1, 2024, for electronic and precision equipment repair and maintenance services for Terumo Trima Accel blood cell processors. The contract, which carries no small business set-aside designation, will be performed in San Diego, California, with an ultimate completion date of October 31, 2027. Terumo BCT Inc., a Colorado-based medical device...
- The Defense Health Agency awarded a firm fixed price purchase order to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technologies, to provide service maintenance for two Spectra Optia Apheresis Machines for a base period of one year and three option years. The total ceiling value of the contract is $53,042. This sole-source award was made under the authority of FAR 13.106-1(b)(1)(i), as Terumo BCT is the original equipment manufacturer and the...
- The Defense Health Agency awarded a firm-fixed-price purchase order contract to Terumo BCT Inc., a foreign-owned, for-profit medical device manufacturer, for the maintenance of TERUMOBCT medical equipment. The contract, valued at $190,103.00, has a period of performance through November 12, 2023. This contract is not set aside for small businesses. Terumo BCT, headquartered in Lakewood, Colorado, is a global leader in developing advanced medical technologies focused on blood processing,...
The Defense Health Agency awarded a $47,107.92 firm fixed-price purchase order to Terumo BCT Inc. (doing business as Caridianbct Inc.) on January 23, 2026, for the provision of a Spectra Optia Apheresis System used for cell processing and cell collection. The system will be delivered to and utilized at the Defense Health Agency's facility in Bethesda, Maryland, with an ultimate completion date of January 22, 2028. This contract was not set aside for small businesses, reflecting the specialized nature of the medical equipment and the contractor's established capabilities in federal procurement markets. Terumo BCT Inc., a foreign-owned medical device manufacturer headquartered in Lakewood, Colorado, specializes in advanced blood and cell technology solutions. The company has a demonstrated track record of providing sophisticated medical equipment and related services to defense and health-focused federal agencies, including the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. The Spectra Optia system represents a critical technology for cell therapy applications within the federal healthcare enterprise, supporting the Defense Health Agency's mission to deliver advanced medical capabilities to military healthcare facilities and personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 1/21/26 |